期刊文献+

白血病患者并发肛周脓肿的相关因素分析 被引量:12

The analysis of related factors of perianal abscess in patients with leukemia
下载PDF
导出
摘要 目的探讨白血病患者并发肛周脓肿的相关因素,为疾病的预防和治疗提供依据。方法选取178例白血病患者的临床资料进行回顾性分析,分析白血病患者并发肛周脓肿的相关因素。结果经单因素分析,患者年龄、疾病种类、治疗过程中血清总蛋白计数、白细胞计数、中性粒细胞计数、肛周疾患情况、激素及抗生素使用情况、住院时间及患者依从性与白血病患者并发肛周脓肿有关;经多因素Logistic回归分析,患者年龄﹥55岁、白细胞计数≤4×109/L、曾患有肛周疾患、住院时间﹥30 d及患者依从性差为白血病患者并发肛周脓肿的危险因素。结论因白血病患者免疫力较低,并发肛周脓肿的因素也较为多样化,因此,针对性地加强对相关因素的干预是预防白血病患者并发肛周脓肿的关键。 Objective To explore the related factors of perianal abscess in patients with leukemia, and to provide reference for the prevention and treatment of the disease. Method 178 patients with leukemia were included in the analysis, the risk factors of the occurrence of perianal abscess in these patients were analyzed. Result The univariate analysis showed that, age, type of disease, serum total protein count, white blood cell count, neutrophils, conditions of perianal disorders, use of hormone and antibiotics, hospital stay and patients' compliance were associated with the presence of perianal abscess in leukemia patients; and the multivariate Logistic regression analysis indicated that, age〉55 years, white blood cell count≤4×10^9/L, prior history of perianal disorders, hospital stay〉30 d and poor patient compliance were risk factors of perianal abscess in patients with leukemia. Conclusion Because of the low immunity in leukemia patients, the causes of perianal abscess are heterogeneous, and it is the key to prevent the complications of perianal abscess by strengthening the intervention of related factors.
出处 《癌症进展》 2017年第10期1213-1215,共3页 Oncology Progress
关键词 白血病 肛周脓肿 相关性 危险因素 leukemia perianal abscess correlation risk factors
  • 引文网络
  • 相关文献

参考文献9

二级参考文献92

  • 1常曦东,邱幼东,黄俊,邓旺生,易琨.切开引流加挂线术治疗肛周脓肿84例报告[J].中华今日医学杂志,2003,3(21):73-74. 被引量:3
  • 2侯英华.白血病合并口腔感染患者口腔pH值变化的探讨[J].中国实用护理杂志,2006,22(9):25-26. 被引量:22
  • 3李春雨,张有生.实用肛肠外科学[M].北京:人民军医出版社,2009:284-286. 被引量:6
  • 4Appelbaum FR,Gundacker H,Head DR,et al.Age and acute myeloid leukemia[J].Blood,2006,107(9):3481-3485. 被引量:1
  • 5Burnett AK,Hills RK,Milligan DW,et al.Attempts to optimize induction and consolidation treatment in acute myeloid leukemia:results of the MRC AML12 trial[J].J Clin Oncol,2010,28(4):586-595. 被引量:1
  • 6Burnett AK,Milligan D,Goldstone A,et al.The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome:the results of the LRF AML14 trial[J].Br J Haematol,2009,145(3):318-332. 被引量:1
  • 7Sorror ML,Giralt S,Sandmaier BM,et al.Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission:combined FHCRC and MDACC experiences[J].Blood,2007,110(13):4606-4613. 被引量:1
  • 8Martin G,Barragan E,Bolufer P,et al.Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement[J].Haematologica,2000,85(7):699-703. 被引量:1
  • 9Nguyen S,Leblanc T,Fenaux P,et al.A white blood cell index as the main prognostic factor in t(8; 21) acute myeloid leukemia (AML):a survey of 161 cases from the French AML Intergroup[J].Blood,2002,99(10):3517-3523. 被引量:1
  • 10Burnett AK,Grimwade D,Solomon E,et al.Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:result of the Randomized MRC Trial[J].Blood,1999,93(12):4131-4143. 被引量:1

共引文献110

同被引文献146

引证文献12

二级引证文献122

;
使用帮助 返回顶部